If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: OUTSOURCING-PHARMA
Xention: Xention aims to cash in ion channels knowhow through new CRO
Heart drug developer Xention has launched a contract screening business designed for drug industry customers seeking ion channel services.
Read full article »
Xention's Competitors
|
Xention's News
|
Xention's Financials
Follow
Followers on Owler
4
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO
Update CEO
CEO Approval Rating
- -/100
Xention discovers and develops ion channel-modulating drugs.
Read more
See Xention company profile »
